A father fighting for compensation after claiming side effects from the AstraZeneca vaccine has taken a step forward,
His lawyer said.
He says the drug maker has made a “major shift” in its legal position on claims that AstraZeneca’s Covid vaccine caused brain damage to its client.
In court filings, AstraZeneca admitted for the first time that its COVID-19 vaccine could cause very rare side effects.
The pharmaceutical company has faced several complaints regarding its COVID-19 vaccine.
Some complain of the loss of a loved one,
Others of a serious illness. Studies show that AstraZeneca and other coronavirus vaccines have saved millions of lives. Click Here:
Jimmy Scott, a father of two, made the first allegation on the subject last year. He claims he is unable to work as a result of brain damage caused
The lawsuit, filed under UK consumer protection laws,
claimed the vaccine was “defective.” The reason is that the vaccine was not as safe as expected.
The first coronavirus vaccine introduced in the United States was AstraZeneca, which was administered at a Birmingham mosque in January 2021.
AstraZeneca has disputed those claims,
but the company admitted in a legal document it submitted to the country’s Supreme Court in February that its Coved vaccine “can, in very rare cases, cause TTS.
Lawyers in the case say TTS stands for thrombosis with thrombocytopenia syndrome.
When this occurs after vaccination,
it is also referred to as VTT (vaccine-induced immune thrombosis with thrombocytopenia).
TTS/VITT is a rare syndrome in which thrombosis (blood clotting) and thrombocytopenia (low platelet count) occur simultaneously.
TTS/VITT is potentially fatal.
It can also lead to stroke, brain damage, heart attacks, blood clots in the pulmonary artery and amputations, lawyers said.
Many types of blood clots can occur even without vaccination.
However, according to the American Society of Hematology,
the rare TTS/VITT syndrome only applies to post-vaccination blood clots.
It can be caused by a variety of events (not just vaccines) and may have no identifiable cause.
Mr Scott’s lawyers confirmed to the BBC in a letter sent in May 2023 that AstraZeneca told them: “We do not accept that TTS is (largely) caused by vaccines.
Its general mechanism is unknown.”
The organization wants each complainant to prove their claim that the thrombosis, known as TTS, occurred because of the vaccine and for no other reason.
It states: “TTS can also occur in the absence of the AstraZeneca (or any other) vaccine.” Expert evidence is needed to determine the cause in any individual case.
The Serum Institute of India in Maharashtra has collaborated with AstraZeneca to produce at least one billion doses of the COVID-19 vaccine by 2021.
‘A noticeable change’
Lawyers representing a total of 51 plaintiffs, including Scott, said this represents a major change in AstraZeneca’s position in the case.
Sarah Moore, from law firm Lee Day, told the BBC: “This is an important recognition of the common cause, which is that the AstraZeneca vaccine can cause TTS and VIT in certain cases.”
This recognition could pave the way for larger sums of money.
Complainants want fair compensation and some financial security.
AstraZeneca spoke to the BBC on Tuesday but did not comment on the issues raised by Sarah Moore.
More News: Under the pretext of constructing a 250-meter drain, two kilometers of roads are cut down!
The AstraZeneca vaccine was launched globally less than a year after the lockdown began outside China, with this health worker being vaccinated in Kenya in March 2021.
